Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-04

Clinical Trial Update: Study of Teduglutide in Japanese Participants With Short Bowel Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial of teduglutide in Japanese participants with Short Bowel Syndrome has completed and results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teduglutide (teduglutide)

Snippet

Sponsor: Shire | Conditions: Short Bowel Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2020-08-04